Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02962128 · ClinicalTrials.gov registry record · NA
Role of Polyunsaturated Fatty Acids (PUFA)-Gene Interactions in Heath Disparities
A NA study of Fatty Acid-Gene Interactions, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT02962128 is a NA study of Fatty Acid-Gene Interactions that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02962128, a NA study of Fatty Acid-Gene Interactions, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, clinical trial to provide the first comprehensive investigation of the role of fatty acid desaturate (FADS) genetic determinants on PUFA biosynthesis and metabolism as well as levels of inflammatory markers in a controlled dietary environment using two (low and high linoleic acid) parallel diets.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT High Linoleic Acid (LA) Diet
- DIETARY_SUPPLEMENT Low Linoleic Acid (LA) Diet
Study Locations (1)
North Carolina
- Wake Forest Baptist Medical Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-11-29 |
| Est. Completion | 2021-12-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02962128
The ClinicalTrials.gov registry entry for NCT02962128 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fatty Acid-Gene Interactions appearing as the primary indexed condition, and to 2 interventions - of which High Linoleic Acid (LA) Diet is the first listed.
NCT02962128 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02962128 about?
NCT02962128 is a clinical study titled "Role of Polyunsaturated Fatty Acids (PUFA)-Gene Interactions in Heath Disparities". A randomized, clinical trial to provide the first comprehensive investigation of the role of fatty acid desaturate (FADS) genetic determinants on PUFA biosynthesis and metabolism as well as levels of inflammatory markers in a controlled dietary environment using two (low and high linoleic acid) para...
What is the current status of trial NCT02962128?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2016-11-29. Estimated completion is 2021-12-14.
What conditions does trial NCT02962128 study?
This clinical trial studies the following conditions: Fatty Acid-Gene Interactions.
What interventions are being tested in trial NCT02962128?
The interventions under investigation include: High Linoleic Acid (LA) Diet (DIETARY_SUPPLEMENT), Low Linoleic Acid (LA) Diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02962128?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02962128 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.